Global Psychedelics
Welcome to GLOBAL Psychedelic WEBSITE
Free Shipping
Free Shipping On All Order
Money Guarantee
5 Days Money Back
Online Support 24/7
Technical Support 24/7
Secure Payment
All Cards Accepted
20 % OFF
fine smile
Sales
The global psychedelic drugs market size was valued at USD 2.9 billion in 2023 and is projected to reach USD 8.7 billion by 2033, with a Compound Annual Growth Rate (CAGR) of 11.61%. The market includes a variety of psychedelic substances such as psilocybin, LSD, MDMA, DMT, and ketamine. These substances are being researched for their therapeutic potential in treating various mental health conditions like depression, anxiety, and PTSD.
Best Products
Gelato
Mango Haze
Gorilla Glue #4
Purple Kush
Shishkaberry
20 % OFF
HAPPY HOURS
Key Players in the Global Psychedelic Drugs Market
Several companies are actively involved in the development and commercialization of psychedelic drugs. Some key players in this market include Compass Pathways, MindMed, Field Trip Health, Cybin Inc., Atai Life Sciences, Numinus Wellness, Eleusis, Mydecine Innovations Group, HAVN Life Sciences, Silo Pharma, Revive Therapeutics, NeonMind Biosciences, Entheon Biomedical, Tryp Therapeutics, Beckley Psytech, GH Research, Psyched Wellness among others.